Argitalpenak (44) Fayna María García Martín argitalpenak

2023

  1. Design of cancer vaccines based on muc1-like glycopeptides and mesoporous silica nanoparticles

    XXXIX Reunión Bienal de la Sociedad Española de Química - RSEQ - Zaragoza 2023. Abstracts Book

  2. Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate

    VI RSEQ Chemical Biology Group Meeting - ChemBio VI

  3. SYNTHESIS OF CANCER VACCINES INCORPORATING MUC1-LIKE GLYCOPEPTIDES AND MESOPOROUS SILICA NANOPARTICLES

    XIII Jornadas de Carbohidratos (Spanish Carbohydrate Meeting). Book of Abstracts

  4. Strategies for Glycan Multipresentation

    I Glycoforum La Rioja-Euskadi-Hokkaido

  5. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au

2022

  1. Aplicación de la Realidad Aumentada en la Enseñanza de la Química

    Jornadas de Innovación Docente UR-CRIE 2022: #InnovaDocenteUR : Libro de resúmenes

  2. Desing of cancer vaccines based on MUC1-Like Glycopeptides Containing Non-Natural Amino Acids

    XXXVIII Reunión Bienal de la Real Sociedad Española de Química - RSEQ 2022 (Abstracts book)

  3. Guía para la incorporación de la perspectiva de género en los Trabajos Finales de Grado y Máster de la Universidad de La Rioja

    Gobierno de La Rioja

  4. Inhibitory role of Annexin A1 in pathological bone resorption and therapeutic implications in periprosthetic osteolysis

    Nature Communications, Vol. 13, Núm. 1

  5. Structure-based Design of Anti-cancer Vaccines: The Significance of Antigen Presentation to Boost the Immune Response

    Current Medicinal Chemistry, Vol. 29, Núm. 7, pp. 1258-1270

  6. What Is and Is Not Key in the Recognition of Mucin1 Glycopeptide by the Immune System

    4th Glycobasque Meeting

2021

  1. Design of cancer vaccines based on the use of non-natural glycopeptides with β-amino acids

    XVII Simposio de Investigadores Jóvenes RSEQ. Libro de resúmenes

  2. Diseño de vacunas terapéuticas contra el cáncer basadas en glicopéptidos no naturales

    XI Jornada de Química CISQ

  3. El qué, cómo y cuándo de los Test de Detección de COVID-19

    Zubía, Núm. 39, pp. 233-242

2020

  1. A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes

    Chemical Science, Vol. 11, Núm. 19, pp. 4999-5006

  2. Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics

    Journal of medicinal chemistry, Vol. 63, Núm. 15, pp. 8524-8533

  3. Correction: A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes (Chem. Sci. (2020) 11 (4999-5006) DOI: 10.1039/D0SC00317D)

    Chemical Science

  4. Impaired O-Glycosylation at Consecutive Threonine TTX Motifs in Mucins Generates Conformationally Restricted Cancer Neoepitopes

    Biochemistry, Vol. 59, Núm. 12, pp. 1221-1241

  5. Synthesis, conformational analysis and: In vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment

    Chemical Science, Vol. 11, Núm. 15, pp. 3996-4006

2018

  1. CLEC10A Is a specific marker for human CD1c+ dendritic cells and enhances their toll-like receptor 7/8-Induced cytokine secretion

    Frontiers in Immunology, Vol. 9, Núm. APR